Taiantang Pharmaceutical

Guangdong Taiantang Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and production of Traditional Chinese Medicine (TCM) and topical dermatological treatments. Headquartered in Shantou, Guangdong, the company leverages the heritage of the centuries-old "Taiantang" brand to focus on therapeutic areas including dermatology, reproductive health, cardiovascular care, and pediatrics. Its flagship products include Qilin Pills for infertility and various medicated ointments such as Shezhi Shenhuang and Piyankang for chronic skin conditions. Although a major player in the TCM sector for decades, the company was delisted from the Shenzhen Stock Exchange in July 2024 following sustained financial difficulties and regulatory challenges. Taiantang continues to operate its integrated manufacturing and R&D facilities, serving the domestic Chinese market through an extensive distribution network.